News | January 11, 2024
Aarti Pharmalabs sets up R&D Centre in Navi Mumbai
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
Atlas AI combines NVIDIA BioNeMo cloud APIs for intelligent chemical and protein design
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Signs MoU with the Govt. of Gujarat at Vibrant Gujarat Summit
Arco Lab now holds a 50% stake in Neviton
The company received gross proceeds of approximately US$1.7 million and net proceeds,
Ribo's cutting edge RIBO-GalSTAR platform enables the development of RNAi therapeutics targeting disease-causing genes specifically in hepatocytes
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant
Development services for gene and cell therapies is planned to begin first in 2025
Subscribe To Our Newsletter & Stay Updated
